Literature DB >> 2015564

Patterns of care related to age of men with prostate cancer.

C L Bennett1, S Greenfield, H Aronow, P Ganz, N J Vogelzang, R M Elashoff.   

Abstract

A chart review study was done of 242 Stages A2 to D1 cancer patients to determine whether the age of patients with prostate cancer influenced their physicians' management strategies. Ten hospitals of varying size, medical-school affiliation, and patient socioeconomic status participated in this study. Patterns of prostate cancer care were examined using sets of branching logic standards in the form of criteria maps. A chart-based comorbidity index was used to control for the effect of coexisting diseases on cancer management. Regression models indicated that patient age affected the intensity of both the diagnostic evaluation and therapy, even after controlling for independent factors such as comorbid disease and individual hospital differences. Patients aged 75 years and older had significantly less intensive clinical staging workups and use of surgical and radiation therapies compared with patients aged 65 to 74 years and patients aged 50 to 64 years. In conjunction with similar results noted in studies of elderly patients with other malignancies, these results suggest that age bias is likely to be widespread. Physicians need to consider life expectancy, the ability of the patient to tolerate diagnostic procedures and therapies, and the quality of life in making treatment decisions.

Entities:  

Mesh:

Year:  1991        PMID: 2015564     DOI: 10.1002/1097-0142(19910515)67:10<2633::aid-cncr2820671039>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Defining treatment aims and end-points in older patients with cancer.

Authors:  C E Desch; T J Smith
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

2.  The association between age of hospitalized patients and the delivery of advanced cardiac life support.

Authors:  T R Fried; M A Miller; M D Stein; T J Wachtel
Journal:  J Gen Intern Med       Date:  1996-05       Impact factor: 5.128

3.  [Robot-assisted radical prostatectomy in elderly patients: surgical, oncological and functional outcomes].

Authors:  D Porres; D Pfister; A P Labanaris; V Zugor; J H Witt; A Heidenreich
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

4.  Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data.

Authors:  Anthony F Jerant; Peter Franks; J Elizabeth Jackson; Mark P Doescher
Journal:  Ann Fam Med       Date:  2004 Sep-Oct       Impact factor: 5.166

5.  Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status.

Authors:  A P Polednak
Journal:  J Natl Med Assoc       Date:  1998-02       Impact factor: 1.798

6.  Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness.

Authors:  Karen E Hoffman; Bridget A Neville; Harvey J Mamon; Lisa A Kachnic; Matthew S Katz; Craig C Earle; Rinaa S Punglia
Journal:  Cancer       Date:  2011-06-20       Impact factor: 6.860

7.  The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.

Authors:  Kai-Tai Liu; Jue-Feng Wan; Gen-Hua Yu; Yan-Ping Bei; Xue Chen; Miao-Zhen Lu
Journal:  J Cancer Res Clin Oncol       Date:  2016-10-18       Impact factor: 4.553

8.  Prostate cancer in elderly men.

Authors:  Anton Stangelberger; Matthias Waldert; Bob Djavan
Journal:  Rev Urol       Date:  2008

9.  Lumbar spine surgery and mortality among Medicare beneficiaries, 1986.

Authors:  N B Oldridge; Z Yuan; J E Stoll; A R Rimm
Journal:  Am J Public Health       Date:  1994-08       Impact factor: 9.308

10.  Low-dose rate brachytherapy of the prostate in elderly patients.

Authors:  C Chiumento; A Fiorentino; R Caivano; S Clemente; V Fusco
Journal:  Radiol Med       Date:  2012-09-17       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.